638 related articles for article (PubMed ID: 27919707)
1. Autoimmune Cardiotoxicity of Cancer Immunotherapy.
Cheng F; Loscalzo J
Trends Immunol; 2017 Feb; 38(2):77-78. PubMed ID: 27919707
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue.
Varricchi G; Marone G; Mercurio V; Galdiero MR; Bonaduce D; Tocchetti CG
Curr Med Chem; 2018; 25(11):1327-1339. PubMed ID: 28403786
[TBL] [Abstract][Full Text] [Related]
3. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.
Pitt JM; Vétizou M; Daillère R; Roberti MP; Yamazaki T; Routy B; Lepage P; Boneca IG; Chamaillard M; Kroemer G; Zitvogel L
Immunity; 2016 Jun; 44(6):1255-69. PubMed ID: 27332730
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin.
Jain V; Mohebtash M; Rodrigo ME; Ruiz G; Atkins MB; Barac A
J Immunother; 2018 Sep; 41(7):332-335. PubMed ID: 29965858
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapy in patients with preexisting autoimmune disorders.
Donia M; Pedersen M; Svane IM
Semin Immunopathol; 2017 Apr; 39(3):333-337. PubMed ID: 27730287
[TBL] [Abstract][Full Text] [Related]
6. The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.
Demlova R; Valík D; Obermannova R; ZdraŽilová-Dubská L
Physiol Res; 2016 Dec; 65(Suppl 4):S455-S462. PubMed ID: 28006927
[TBL] [Abstract][Full Text] [Related]
7. Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity.
Zhang JC; Chen WD; Alvarez JB; Jia K; Shi L; Wang Q; Zou N; He K; Zhu H
Acta Pharmacol Sin; 2018 Nov; 39(11):1693-1698. PubMed ID: 29991709
[TBL] [Abstract][Full Text] [Related]
8. Adapting Cancer Immunotherapy Models for the Real World.
Klevorn LE; Teague RM
Trends Immunol; 2016 Jun; 37(6):354-363. PubMed ID: 27105824
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.
Sun L; Chen L; Li H
Int Immunopharmacol; 2019 Feb; 67():160-175. PubMed ID: 30553199
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment.
Cappelli LC; Naidoo J; Bingham CO; Shah AA
Immunotherapy; 2017 Jan; 9(1):5-8. PubMed ID: 28000525
[No Abstract] [Full Text] [Related]
11. Immunotherapy of colorectal cancer: new perspectives after a long path.
Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
[TBL] [Abstract][Full Text] [Related]
12. Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition.
Dein E; Sharfman W; Kim J; Gellad F; Shah AA; Bingham CO; Cappelli LC
J Immunother; 2017 Oct; 40(8):312-314. PubMed ID: 28614096
[TBL] [Abstract][Full Text] [Related]
13. Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy.
Tajmir-Riahi A; Bergmann T; Schmid M; Agaimy A; Schuler G; Heinzerling L
J Immunother; 2018 Jan; 41(1):35-38. PubMed ID: 29077601
[TBL] [Abstract][Full Text] [Related]
14. Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
Johnson DB; Balko JM; Compton ML; Chalkias S; Gorham J; Xu Y; Hicks M; Puzanov I; Alexander MR; Bloomer TL; Becker JR; Slosky DA; Phillips EJ; Pilkinton MA; Craig-Owens L; Kola N; Plautz G; Reshef DS; Deutsch JS; Deering RP; Olenchock BA; Lichtman AH; Roden DM; Seidman CE; Koralnik IJ; Seidman JG; Hoffman RD; Taube JM; Diaz LA; Anders RA; Sosman JA; Moslehi JJ
N Engl J Med; 2016 Nov; 375(18):1749-1755. PubMed ID: 27806233
[TBL] [Abstract][Full Text] [Related]
15. Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.
Cooper MR; Alrajhi AM; Durand CR
Am J Ther; 2018; 25(3):e349-e356. PubMed ID: 29722737
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapies: Exploiting the Immune System for Cancer Treatment.
Koury J; Lucero M; Cato C; Chang L; Geiger J; Henry D; Hernandez J; Hung F; Kaur P; Teskey G; Tran A
J Immunol Res; 2018; 2018():9585614. PubMed ID: 29725606
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for kidney cancer: status quo and the future.
Bedke J; Stühler V; Stenzl A; Brehmer B
Curr Opin Urol; 2018 Jan; 28(1):8-14. PubMed ID: 29120911
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of cancers comes of age.
Yousefi H; Yuan J; Keshavarz-Fathi M; Murphy JF; Rezaei N
Expert Rev Clin Immunol; 2017 Oct; 13(10):1001-1015. PubMed ID: 28795649
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in melanoma.
Feld E; Mitchell TC
Immunotherapy; 2018 Aug; 10(11):987-998. PubMed ID: 30149766
[TBL] [Abstract][Full Text] [Related]
20. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
